BETA: Please send your feedback!
Human Metabolome Technologies
6090-JP:TKS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
About
Biotechnology
Founded 2003
Human Metabolome Technologies, Inc. engages in diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients. The Biomarker segment deals with the development of biomarker license in collaboration with the group companies. The Temporary Staffing segment provides researchers and technicians. The company was founded by Yoshihiro Otaki, Masaru Tomita, and Tomoyoshi Soga in July 1, 2003 and is headquartered in Tsuruoka, Japan.
website
Headquarters
Executives
| Name | Title | Gender |
| Yoshihiro Otaki, PhD | Founder | Male |
| Tomoyoshi Soga, PhD | Founder | Male |
| Ryuji Kanno | President & Representative Director | Male |
| Masaru Tomita, PhD | Founder | Male |
| Tetsuya Hasegawa, CPA | Director & General Manager-Business Administration | Male |
| Toshiyasu Miyazaki | Director, Head-Technology Development & Bio Maker | Male |
Mindful Investing Summary
Human Metabolome Technologies - Competitors and Related Companies
How Human Metabolome Technologies stacks up to its peers in the Biotechnology industry or with competing business segments.
Human Metabolome Technologies
6090-JP:TKS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
Loading…